Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sexual Behavior | 23 | 2022 | 301 | 6.220 |
Why?
|
Sexual Dysfunction, Physiological | 13 | 2018 | 67 | 4.660 |
Why?
|
Referral and Consultation | 10 | 2021 | 326 | 3.660 |
Why?
|
Sexual Dysfunctions, Psychological | 7 | 2022 | 32 | 3.050 |
Why?
|
Caregivers | 7 | 2023 | 151 | 2.830 |
Why?
|
Urban Population | 8 | 2019 | 213 | 2.790 |
Why?
|
Health Status | 13 | 2018 | 360 | 2.430 |
Why?
|
Dementia | 4 | 2023 | 187 | 2.290 |
Why?
|
Health Surveys | 8 | 2011 | 238 | 2.070 |
Why?
|
Sexuality | 9 | 2015 | 40 | 1.990 |
Why?
|
Prescription Drugs | 4 | 2018 | 36 | 1.910 |
Why?
|
Poverty | 8 | 2019 | 171 | 1.900 |
Why?
|
Genital Neoplasms, Female | 5 | 2015 | 107 | 1.790 |
Why?
|
Community Health Centers | 3 | 2019 | 113 | 1.790 |
Why?
|
Aging | 9 | 2010 | 689 | 1.770 |
Why?
|
Socioeconomic Factors | 10 | 2023 | 567 | 1.770 |
Why?
|
Myocardial Infarction | 6 | 2016 | 372 | 1.760 |
Why?
|
Health Promotion | 3 | 2019 | 160 | 1.730 |
Why?
|
Female | 91 | 2023 | 44405 | 1.720 |
Why?
|
Pandemics | 8 | 2023 | 739 | 1.690 |
Why?
|
Food Supply | 6 | 2022 | 28 | 1.680 |
Why?
|
Gynecology | 5 | 2022 | 124 | 1.660 |
Why?
|
Community Health Services | 3 | 2021 | 80 | 1.610 |
Why?
|
Primary Health Care | 7 | 2021 | 339 | 1.600 |
Why?
|
Humans | 117 | 2023 | 86281 | 1.580 |
Why?
|
Dietary Supplements | 3 | 2019 | 128 | 1.570 |
Why?
|
Pharmacies | 2 | 2021 | 6 | 1.550 |
Why?
|
United States | 41 | 2023 | 6637 | 1.550 |
Why?
|
Data Interpretation, Statistical | 5 | 2009 | 297 | 1.510 |
Why?
|
Middle Aged | 59 | 2022 | 24957 | 1.470 |
Why?
|
Health Resources | 3 | 2019 | 76 | 1.460 |
Why?
|
Electronic Prescribing | 3 | 2019 | 11 | 1.460 |
Why?
|
Residence Characteristics | 9 | 2023 | 195 | 1.430 |
Why?
|
Chicago | 17 | 2021 | 1377 | 1.400 |
Why?
|
Social Behavior | 5 | 2009 | 294 | 1.390 |
Why?
|
Obstetrics | 3 | 2022 | 120 | 1.380 |
Why?
|
Aged | 44 | 2023 | 18353 | 1.350 |
Why?
|
Aged, 80 and over | 25 | 2021 | 6481 | 1.290 |
Why?
|
Obesity | 5 | 2018 | 962 | 1.280 |
Why?
|
Qualitative Research | 6 | 2020 | 256 | 1.250 |
Why?
|
Cross-Sectional Studies | 21 | 2023 | 1610 | 1.220 |
Why?
|
Health Services Accessibility | 6 | 2021 | 392 | 1.210 |
Why?
|
Adult | 48 | 2023 | 25577 | 1.160 |
Why?
|
Cardiovascular Diseases | 5 | 2020 | 826 | 1.140 |
Why?
|
Uterine Cervical Neoplasms | 6 | 2012 | 274 | 1.060 |
Why?
|
Adolescent | 24 | 2022 | 8968 | 1.050 |
Why?
|
Male | 52 | 2023 | 40860 | 1.030 |
Why?
|
Hypertension | 5 | 2019 | 1139 | 1.020 |
Why?
|
Sexual Partners | 4 | 2015 | 93 | 1.000 |
Why?
|
Postmenopause | 3 | 2019 | 98 | 0.980 |
Why?
|
Healthcare Disparities | 4 | 2017 | 369 | 0.980 |
Why?
|
Self-Management | 2 | 2020 | 29 | 0.940 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2011 | 44 | 0.940 |
Why?
|
Pregnancy, Ectopic | 2 | 2016 | 36 | 0.940 |
Why?
|
Survivors | 3 | 2015 | 225 | 0.930 |
Why?
|
HIV Infections | 6 | 2011 | 768 | 0.920 |
Why?
|
Depression | 6 | 2023 | 472 | 0.920 |
Why?
|
Population Health | 3 | 2019 | 33 | 0.910 |
Why?
|
Diabetes Mellitus | 6 | 2021 | 801 | 0.900 |
Why?
|
Food Assistance | 1 | 2022 | 2 | 0.890 |
Why?
|
Vaginal Smears | 6 | 2017 | 68 | 0.890 |
Why?
|
Young Adult | 18 | 2021 | 5961 | 0.870 |
Why?
|
Mass Screening | 10 | 2023 | 615 | 0.870 |
Why?
|
Medical Informatics | 3 | 2019 | 47 | 0.860 |
Why?
|
Electronic Health Records | 4 | 2021 | 319 | 0.850 |
Why?
|
Communication | 4 | 2016 | 438 | 0.850 |
Why?
|
Health Information Exchange | 1 | 2021 | 12 | 0.830 |
Why?
|
Sex Factors | 10 | 2018 | 1053 | 0.830 |
Why?
|
Systems Analysis | 1 | 2021 | 17 | 0.830 |
Why?
|
Vagina | 4 | 2019 | 161 | 0.820 |
Why?
|
Breast Neoplasms | 5 | 2023 | 2881 | 0.820 |
Why?
|
Community Networks | 1 | 2021 | 29 | 0.810 |
Why?
|
Drug Utilization | 3 | 2018 | 65 | 0.810 |
Why?
|
Mental Health | 3 | 2023 | 160 | 0.800 |
Why?
|
Surveys and Questionnaires | 14 | 2023 | 2495 | 0.800 |
Why?
|
Prevalence | 9 | 2019 | 1239 | 0.790 |
Why?
|
Educational Status | 5 | 2013 | 187 | 0.780 |
Why?
|
Administrative Personnel | 1 | 2020 | 8 | 0.780 |
Why?
|
Violence | 3 | 2019 | 143 | 0.780 |
Why?
|
Self Care | 2 | 2019 | 164 | 0.780 |
Why?
|
Patient Education as Topic | 2 | 2020 | 351 | 0.760 |
Why?
|
Poverty Areas | 3 | 2018 | 37 | 0.760 |
Why?
|
Vaginal Neoplasms | 2 | 2012 | 83 | 0.730 |
Why?
|
Estrogens | 2 | 2019 | 197 | 0.730 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2013 | 508 | 0.710 |
Why?
|
Urban Health | 2 | 2016 | 55 | 0.690 |
Why?
|
Cities | 2 | 2016 | 40 | 0.680 |
Why?
|
Cooperative Behavior | 2 | 2018 | 174 | 0.680 |
Why?
|
Smoking Cessation | 2 | 2019 | 230 | 0.670 |
Why?
|
Antihypertensive Agents | 2 | 2013 | 521 | 0.670 |
Why?
|
Social Determinants of Health | 4 | 2019 | 78 | 0.660 |
Why?
|
Independent Living | 1 | 2018 | 18 | 0.660 |
Why?
|
Quality of Life | 8 | 2023 | 1575 | 0.650 |
Why?
|
Interinstitutional Relations | 1 | 2018 | 28 | 0.640 |
Why?
|
Stakeholder Participation | 1 | 2018 | 19 | 0.640 |
Why?
|
Homicide | 1 | 2018 | 34 | 0.640 |
Why?
|
Data Collection | 4 | 2016 | 371 | 0.630 |
Why?
|
Stress, Psychological | 1 | 2021 | 313 | 0.630 |
Why?
|
Drug Prescriptions | 1 | 2019 | 141 | 0.630 |
Why?
|
Body Mass Index | 4 | 2021 | 770 | 0.620 |
Why?
|
Vulvodynia | 2 | 2016 | 3 | 0.610 |
Why?
|
Vaginal Diseases | 1 | 2017 | 27 | 0.610 |
Why?
|
Pharmaceutical Services | 1 | 2017 | 9 | 0.600 |
Why?
|
Child | 11 | 2023 | 6913 | 0.600 |
Why?
|
City Planning | 1 | 2016 | 4 | 0.590 |
Why?
|
Medicare | 5 | 2023 | 404 | 0.580 |
Why?
|
Commerce | 1 | 2016 | 29 | 0.570 |
Why?
|
Counseling | 2 | 2014 | 144 | 0.570 |
Why?
|
Cognitive Dysfunction | 1 | 2018 | 132 | 0.570 |
Why?
|
Neoplasms | 5 | 2023 | 2889 | 0.560 |
Why?
|
Endometrial Neoplasms | 1 | 2018 | 191 | 0.560 |
Why?
|
Blood Pressure | 2 | 2019 | 1143 | 0.550 |
Why?
|
Gynecological Examination | 1 | 2016 | 17 | 0.550 |
Why?
|
Physician-Patient Relations | 5 | 2014 | 610 | 0.550 |
Why?
|
Pregnancy | 8 | 2023 | 2885 | 0.550 |
Why?
|
Interviews as Topic | 6 | 2019 | 319 | 0.530 |
Why?
|
Hospitals, Urban | 1 | 2015 | 54 | 0.520 |
Why?
|
Academic Medical Centers | 1 | 2018 | 377 | 0.520 |
Why?
|
Biomedical Research | 3 | 2019 | 375 | 0.520 |
Why?
|
Hospitals, Pediatric | 1 | 2015 | 106 | 0.500 |
Why?
|
Pregnancy Outcome | 1 | 2016 | 247 | 0.500 |
Why?
|
Risk Factors | 10 | 2022 | 5397 | 0.500 |
Why?
|
Continuity of Patient Care | 1 | 2016 | 169 | 0.490 |
Why?
|
Interpersonal Relations | 3 | 2011 | 170 | 0.490 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2005 | 105 | 0.490 |
Why?
|
Estradiol | 2 | 2019 | 249 | 0.480 |
Why?
|
Community Health Workers | 2 | 2021 | 26 | 0.470 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 1030 | 0.470 |
Why?
|
Pityriasis Rosea | 1 | 2013 | 2 | 0.470 |
Why?
|
Nortriptyline | 1 | 2013 | 6 | 0.460 |
Why?
|
Information Services | 1 | 2013 | 23 | 0.450 |
Why?
|
Women's Health | 2 | 2006 | 100 | 0.450 |
Why?
|
Health Behavior | 4 | 2010 | 183 | 0.440 |
Why?
|
Antidepressive Agents | 1 | 2013 | 106 | 0.440 |
Why?
|
Health Literacy | 1 | 2013 | 70 | 0.430 |
Why?
|
Maternal Welfare | 1 | 2011 | 9 | 0.420 |
Why?
|
Focus Groups | 3 | 2021 | 153 | 0.420 |
Why?
|
Registries | 2 | 2013 | 702 | 0.420 |
Why?
|
Social Support | 4 | 2023 | 193 | 0.400 |
Why?
|
Delivery of Health Care | 8 | 2023 | 423 | 0.400 |
Why?
|
Health Care Coalitions | 1 | 2011 | 9 | 0.400 |
Why?
|
Love | 1 | 2011 | 9 | 0.400 |
Why?
|
Cell Phone | 1 | 2011 | 37 | 0.390 |
Why?
|
Papanicolaou Test | 3 | 2006 | 38 | 0.390 |
Why?
|
Community-Institutional Relations | 1 | 2011 | 29 | 0.390 |
Why?
|
Los Angeles | 2 | 2021 | 28 | 0.390 |
Why?
|
Community-Based Participatory Research | 1 | 2011 | 36 | 0.390 |
Why?
|
Students | 1 | 2012 | 146 | 0.380 |
Why?
|
Logistic Models | 6 | 2015 | 1184 | 0.380 |
Why?
|
Medicaid | 4 | 2023 | 216 | 0.380 |
Why?
|
Mothers | 1 | 2011 | 140 | 0.380 |
Why?
|
Pharmacists | 2 | 2021 | 32 | 0.380 |
Why?
|
Population Dynamics | 1 | 2011 | 130 | 0.380 |
Why?
|
Professional-Patient Relations | 2 | 2011 | 53 | 0.380 |
Why?
|
Longitudinal Studies | 5 | 2021 | 1015 | 0.370 |
Why?
|
Patient Discharge | 2 | 2023 | 296 | 0.370 |
Why?
|
Insurance Coverage | 1 | 2011 | 115 | 0.360 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 850 | 0.360 |
Why?
|
Needs Assessment | 1 | 2010 | 154 | 0.360 |
Why?
|
Sensation | 1 | 2009 | 45 | 0.340 |
Why?
|
Nonprescription Drugs | 1 | 2008 | 15 | 0.340 |
Why?
|
Patients | 2 | 2019 | 100 | 0.340 |
Why?
|
Internet | 1 | 2011 | 309 | 0.340 |
Why?
|
Papillomavirus Infections | 2 | 2009 | 239 | 0.340 |
Why?
|
Anxiety | 3 | 2023 | 287 | 0.330 |
Why?
|
Abortion, Induced | 2 | 2008 | 120 | 0.330 |
Why?
|
Pain | 3 | 2023 | 389 | 0.330 |
Why?
|
Alphapapillomavirus | 1 | 2008 | 45 | 0.330 |
Why?
|
Sex Counseling | 1 | 2008 | 3 | 0.320 |
Why?
|
Sex Education | 1 | 2008 | 9 | 0.320 |
Why?
|
Research | 2 | 2015 | 253 | 0.320 |
Why?
|
Reproductive Medicine | 1 | 2008 | 9 | 0.320 |
Why?
|
Interdisciplinary Communication | 2 | 2013 | 130 | 0.320 |
Why?
|
Spain | 3 | 2016 | 33 | 0.310 |
Why?
|
Patient Acceptance of Health Care | 2 | 2009 | 237 | 0.310 |
Why?
|
Moral Obligations | 1 | 2008 | 52 | 0.310 |
Why?
|
Prejudice | 1 | 2008 | 49 | 0.310 |
Why?
|
Length of Stay | 1 | 2011 | 697 | 0.310 |
Why?
|
Androgens | 2 | 2009 | 164 | 0.310 |
Why?
|
Religion | 1 | 2008 | 87 | 0.310 |
Why?
|
Testosterone | 1 | 2009 | 268 | 0.300 |
Why?
|
Alcoholism | 1 | 2009 | 170 | 0.300 |
Why?
|
Hospitalization | 2 | 2012 | 844 | 0.300 |
Why?
|
Smoking | 2 | 2023 | 605 | 0.300 |
Why?
|
Comorbidity | 5 | 2016 | 943 | 0.300 |
Why?
|
Adolescent Behavior | 1 | 2008 | 106 | 0.290 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2007 | 122 | 0.290 |
Why?
|
Teaching | 1 | 2008 | 147 | 0.290 |
Why?
|
Quality Improvement | 2 | 2020 | 423 | 0.280 |
Why?
|
Alcohol Drinking | 1 | 2009 | 264 | 0.280 |
Why?
|
HIV Seroprevalence | 1 | 2005 | 9 | 0.270 |
Why?
|
Zidovudine | 1 | 2005 | 16 | 0.270 |
Why?
|
Prospective Studies | 6 | 2022 | 4194 | 0.270 |
Why?
|
Preventive Medicine | 2 | 2002 | 17 | 0.260 |
Why?
|
Self Report | 3 | 2016 | 287 | 0.260 |
Why?
|
Drug Interactions | 3 | 2018 | 248 | 0.260 |
Why?
|
Vulnerable Populations | 1 | 2005 | 76 | 0.250 |
Why?
|
Health Education | 2 | 2021 | 100 | 0.250 |
Why?
|
Contraception | 2 | 2021 | 88 | 0.250 |
Why?
|
Patient Reported Outcome Measures | 2 | 2023 | 165 | 0.240 |
Why?
|
Friends | 1 | 2023 | 17 | 0.240 |
Why?
|
Abortion, Legal | 1 | 2023 | 25 | 0.240 |
Why?
|
Infant | 3 | 2018 | 3036 | 0.240 |
Why?
|
Child, Hospitalized | 1 | 2023 | 33 | 0.230 |
Why?
|
Time Factors | 4 | 2019 | 5198 | 0.230 |
Why?
|
Nutrition Surveys | 3 | 2021 | 114 | 0.230 |
Why?
|
Spouses | 2 | 2015 | 33 | 0.230 |
Why?
|
Hospitals | 2 | 2023 | 290 | 0.230 |
Why?
|
Reproducibility of Results | 4 | 2017 | 2699 | 0.230 |
Why?
|
Motivation | 2 | 2018 | 287 | 0.230 |
Why?
|
Anti-HIV Agents | 1 | 2005 | 149 | 0.220 |
Why?
|
Point-of-Care Systems | 1 | 2023 | 141 | 0.220 |
Why?
|
Illinois | 3 | 2011 | 461 | 0.220 |
Why?
|
Rural Population | 1 | 2022 | 136 | 0.210 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 636 | 0.210 |
Why?
|
Age Factors | 2 | 2018 | 1842 | 0.210 |
Why?
|
Outpatients | 1 | 2022 | 94 | 0.200 |
Why?
|
Domestic Violence | 1 | 2021 | 24 | 0.200 |
Why?
|
Health Plan Implementation | 1 | 2021 | 56 | 0.200 |
Why?
|
Private Sector | 1 | 2021 | 19 | 0.200 |
Why?
|
Police | 1 | 2021 | 23 | 0.200 |
Why?
|
Evidence-Based Medicine | 2 | 2015 | 429 | 0.200 |
Why?
|
Intimate Partner Violence | 1 | 2021 | 20 | 0.200 |
Why?
|
Medicine | 1 | 2022 | 89 | 0.200 |
Why?
|
Mastectomy | 1 | 2023 | 234 | 0.200 |
Why?
|
Social Isolation | 1 | 2021 | 67 | 0.190 |
Why?
|
Geography | 1 | 2021 | 223 | 0.190 |
Why?
|
Health Equity | 1 | 2022 | 75 | 0.190 |
Why?
|
Practice Management, Medical | 1 | 2020 | 24 | 0.190 |
Why?
|
Risk Assessment | 3 | 2019 | 2253 | 0.190 |
Why?
|
Physicians | 1 | 2008 | 672 | 0.180 |
Why?
|
Insurance, Health | 1 | 2021 | 158 | 0.180 |
Why?
|
Survival Rate | 2 | 2016 | 1856 | 0.180 |
Why?
|
Health Services Research | 1 | 2020 | 135 | 0.180 |
Why?
|
Models, Theoretical | 1 | 2003 | 480 | 0.180 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 98 | 0.180 |
Why?
|
Social Welfare | 1 | 2019 | 19 | 0.180 |
Why?
|
Vaginal Creams, Foams, and Jellies | 1 | 2019 | 2 | 0.180 |
Why?
|
Menopause | 3 | 2022 | 71 | 0.180 |
Why?
|
Inpatients | 1 | 2023 | 295 | 0.180 |
Why?
|
Comparative Effectiveness Research | 1 | 2020 | 53 | 0.180 |
Why?
|
Censuses | 2 | 2016 | 5 | 0.180 |
Why?
|
Dyspareunia | 1 | 2019 | 19 | 0.180 |
Why?
|
Dilatation | 1 | 2019 | 46 | 0.170 |
Why?
|
Inventions | 1 | 2019 | 13 | 0.170 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 212 | 0.170 |
Why?
|
Physical Abuse | 1 | 2018 | 4 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2011 | 2260 | 0.160 |
Why?
|
Grounded Theory | 1 | 2018 | 7 | 0.160 |
Why?
|
Diet Surveys | 1 | 2017 | 20 | 0.160 |
Why?
|
Computer Simulation | 2 | 2021 | 1077 | 0.160 |
Why?
|
Mammography | 1 | 2021 | 460 | 0.160 |
Why?
|
Reference Values | 2 | 2009 | 673 | 0.160 |
Why?
|
Attitude | 1 | 2018 | 126 | 0.160 |
Why?
|
Radiation Oncology | 1 | 2019 | 119 | 0.150 |
Why?
|
Cancer Survivors | 1 | 2018 | 85 | 0.150 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 387 | 0.150 |
Why?
|
Maternal Mortality | 1 | 2016 | 15 | 0.140 |
Why?
|
Drug Costs | 1 | 2017 | 62 | 0.140 |
Why?
|
Epithelium | 1 | 2017 | 317 | 0.140 |
Why?
|
Hospital Bed Capacity, 100 to 299 | 1 | 2015 | 1 | 0.140 |
Why?
|
Nutrition Disorders | 1 | 2015 | 16 | 0.140 |
Why?
|
Oncologists | 1 | 2016 | 35 | 0.140 |
Why?
|
Menopause, Premature | 1 | 2015 | 3 | 0.130 |
Why?
|
Patient Selection | 1 | 2019 | 685 | 0.130 |
Why?
|
Health Care Surveys | 1 | 2016 | 277 | 0.130 |
Why?
|
Follow-Up Studies | 3 | 2016 | 3616 | 0.130 |
Why?
|
Physical Examination | 1 | 2016 | 149 | 0.130 |
Why?
|
Retrospective Studies | 3 | 2015 | 8431 | 0.130 |
Why?
|
Endoscopy | 1 | 1998 | 331 | 0.130 |
Why?
|
Body Image | 1 | 2015 | 76 | 0.130 |
Why?
|
Practice Patterns, Physicians' | 2 | 2012 | 578 | 0.130 |
Why?
|
Epidemiologic Research Design | 2 | 2011 | 22 | 0.130 |
Why?
|
Infant, Newborn | 3 | 2023 | 2369 | 0.120 |
Why?
|
Cohort Studies | 3 | 2007 | 2759 | 0.120 |
Why?
|
Curriculum | 1 | 1998 | 537 | 0.120 |
Why?
|
Cognition | 1 | 2018 | 570 | 0.120 |
Why?
|
Psychology | 2 | 2010 | 24 | 0.120 |
Why?
|
Telephone | 1 | 2013 | 32 | 0.120 |
Why?
|
Pregnancy Complications | 1 | 2016 | 336 | 0.110 |
Why?
|
Fear | 1 | 2013 | 78 | 0.110 |
Why?
|
Drug Eruptions | 1 | 2013 | 35 | 0.110 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 1987 | 0.110 |
Why?
|
Parents | 1 | 2015 | 269 | 0.110 |
Why?
|
Congresses as Topic | 1 | 2013 | 116 | 0.110 |
Why?
|
Social Conditions | 1 | 2011 | 8 | 0.110 |
Why?
|
Human Rights | 1 | 2011 | 18 | 0.100 |
Why?
|
Brazil | 1 | 2011 | 69 | 0.100 |
Why?
|
Taste Disorders | 1 | 2011 | 7 | 0.100 |
Why?
|
American Heart Association | 1 | 2012 | 92 | 0.100 |
Why?
|
Child, Preschool | 1 | 2018 | 3608 | 0.100 |
Why?
|
Maternal Behavior | 1 | 2011 | 54 | 0.100 |
Why?
|
Administration, Oral | 1 | 2013 | 683 | 0.100 |
Why?
|
Hospitals, Public | 1 | 2011 | 15 | 0.100 |
Why?
|
Minority Groups | 2 | 2022 | 132 | 0.100 |
Why?
|
Obstetric Surgical Procedures | 1 | 2011 | 10 | 0.100 |
Why?
|
Organizational Case Studies | 1 | 2011 | 27 | 0.100 |
Why?
|
Family Characteristics | 1 | 2011 | 46 | 0.100 |
Why?
|
Models, Organizational | 1 | 2011 | 46 | 0.100 |
Why?
|
Patient Care Team | 1 | 2013 | 280 | 0.100 |
Why?
|
Orgasm | 1 | 2010 | 9 | 0.100 |
Why?
|
Risk | 2 | 2010 | 673 | 0.100 |
Why?
|
HIV Seronegativity | 1 | 2010 | 12 | 0.100 |
Why?
|
Olfaction Disorders | 1 | 2011 | 62 | 0.090 |
Why?
|
Libido | 1 | 2010 | 8 | 0.090 |
Why?
|
HIV Seropositivity | 1 | 2010 | 49 | 0.090 |
Why?
|
Medication Adherence | 1 | 2011 | 129 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2010 | 56 | 0.090 |
Why?
|
Poly dA-dT | 2 | 2000 | 2 | 0.090 |
Why?
|
Adaptation, Psychological | 1 | 2011 | 157 | 0.090 |
Why?
|
Universities | 1 | 2011 | 135 | 0.090 |
Why?
|
Life Expectancy | 1 | 2010 | 85 | 0.090 |
Why?
|
Arousal | 1 | 2010 | 170 | 0.090 |
Why?
|
Immunization Programs | 1 | 2009 | 23 | 0.090 |
Why?
|
Utilization Review | 1 | 2009 | 20 | 0.090 |
Why?
|
Social Class | 1 | 2010 | 127 | 0.090 |
Why?
|
Sensory Thresholds | 1 | 2009 | 54 | 0.090 |
Why?
|
Taste | 1 | 2009 | 28 | 0.090 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 2009 | 3 | 0.090 |
Why?
|
Vaginosis, Bacterial | 1 | 2009 | 8 | 0.090 |
Why?
|
Cotinine | 1 | 2009 | 12 | 0.090 |
Why?
|
Aspirin | 1 | 2010 | 156 | 0.090 |
Why?
|
Vision, Ocular | 1 | 2009 | 71 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2010 | 190 | 0.090 |
Why?
|
Estrogen Replacement Therapy | 1 | 2009 | 45 | 0.090 |
Why?
|
Ovariectomy | 1 | 2009 | 81 | 0.080 |
Why?
|
Internship and Residency | 1 | 1998 | 1001 | 0.080 |
Why?
|
Hearing | 1 | 2009 | 59 | 0.080 |
Why?
|
Cost-Benefit Analysis | 2 | 2021 | 450 | 0.080 |
Why?
|
Cell Count | 1 | 2009 | 194 | 0.080 |
Why?
|
Bias | 1 | 2009 | 127 | 0.080 |
Why?
|
Papillomavirus Vaccines | 1 | 2009 | 58 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2011 | 347 | 0.080 |
Why?
|
Specimen Handling | 1 | 2009 | 98 | 0.080 |
Why?
|
Smell | 1 | 2009 | 107 | 0.080 |
Why?
|
Sexual Abstinence | 1 | 2008 | 10 | 0.080 |
Why?
|
Hormone Replacement Therapy | 1 | 2009 | 77 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2009 | 237 | 0.080 |
Why?
|
Rape | 1 | 2008 | 17 | 0.080 |
Why?
|
Touch | 1 | 2009 | 89 | 0.080 |
Why?
|
Saliva | 1 | 2009 | 122 | 0.080 |
Why?
|
Safe Sex | 1 | 2008 | 23 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 376 | 0.080 |
Why?
|
Condoms | 1 | 2008 | 36 | 0.080 |
Why?
|
Paclitaxel | 2 | 2000 | 460 | 0.080 |
Why?
|
Ethics, Clinical | 1 | 2008 | 48 | 0.080 |
Why?
|
Coitus | 1 | 2007 | 20 | 0.080 |
Why?
|
Reproductive Health Services | 1 | 2008 | 19 | 0.080 |
Why?
|
Financing, Government | 1 | 2007 | 23 | 0.080 |
Why?
|
Schools | 1 | 2008 | 66 | 0.080 |
Why?
|
Multivariate Analysis | 1 | 2010 | 997 | 0.080 |
Why?
|
Politics | 1 | 2007 | 50 | 0.080 |
Why?
|
Personal Autonomy | 1 | 2008 | 112 | 0.080 |
Why?
|
Women's Health Services | 1 | 2006 | 15 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2021 | 7949 | 0.070 |
Why?
|
Sexually Transmitted Diseases | 1 | 2008 | 91 | 0.070 |
Why?
|
Incidence | 1 | 2011 | 1568 | 0.070 |
Why?
|
Reproduction | 1 | 2008 | 195 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 378 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 484 | 0.070 |
Why?
|
Pregnancy, High-Risk | 1 | 2005 | 16 | 0.070 |
Why?
|
Self Disclosure | 1 | 2005 | 31 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 924 | 0.070 |
Why?
|
Ethics, Medical | 1 | 2008 | 306 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2009 | 662 | 0.060 |
Why?
|
DNA | 2 | 2000 | 1293 | 0.060 |
Why?
|
Genotype | 1 | 2008 | 1850 | 0.060 |
Why?
|
Polydeoxyribonucleotides | 2 | 2000 | 5 | 0.060 |
Why?
|
Smokers | 1 | 2023 | 41 | 0.060 |
Why?
|
Testis | 1 | 2003 | 152 | 0.060 |
Why?
|
Southeastern United States | 1 | 2022 | 8 | 0.060 |
Why?
|
Housing | 1 | 2023 | 42 | 0.060 |
Why?
|
Organ Specificity | 1 | 2003 | 257 | 0.060 |
Why?
|
Aftercare | 1 | 2023 | 84 | 0.060 |
Why?
|
Surface Plasmon Resonance | 2 | 2000 | 46 | 0.050 |
Why?
|
Income | 1 | 2022 | 75 | 0.050 |
Why?
|
Asia, Western | 1 | 2021 | 2 | 0.050 |
Why?
|
Life Change Events | 1 | 2022 | 48 | 0.050 |
Why?
|
Asia, Southeastern | 1 | 2021 | 16 | 0.050 |
Why?
|
New York City | 1 | 2021 | 59 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 1671 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2003 | 319 | 0.050 |
Why?
|
Communicable Disease Control | 1 | 2021 | 51 | 0.050 |
Why?
|
Attitude to Health | 1 | 2003 | 220 | 0.050 |
Why?
|
San Francisco | 1 | 2021 | 21 | 0.050 |
Why?
|
Polyribonucleotides | 1 | 2000 | 3 | 0.050 |
Why?
|
Fluorenes | 1 | 2000 | 8 | 0.050 |
Why?
|
Nucleosides | 1 | 2000 | 22 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 222 | 0.050 |
Why?
|
Nucleic Acids | 1 | 2000 | 30 | 0.050 |
Why?
|
Patient Outcome Assessment | 1 | 2021 | 83 | 0.050 |
Why?
|
Prostate | 1 | 2003 | 374 | 0.050 |
Why?
|
Consumer Health Informatics | 1 | 2019 | 3 | 0.050 |
Why?
|
Administration, Intravaginal | 1 | 2019 | 7 | 0.050 |
Why?
|
Patient Compliance | 1 | 2001 | 226 | 0.040 |
Why?
|
Bisbenzimidazole | 1 | 1998 | 1 | 0.040 |
Why?
|
Tilorone | 1 | 1998 | 1 | 0.040 |
Why?
|
Hematoporphyrin Derivative | 1 | 1998 | 3 | 0.040 |
Why?
|
Health Policy | 1 | 2001 | 180 | 0.040 |
Why?
|
Intercalating Agents | 1 | 1998 | 12 | 0.040 |
Why?
|
Nucleic Acid Conformation | 4 | 2000 | 332 | 0.040 |
Why?
|
Patient Preference | 1 | 2019 | 104 | 0.040 |
Why?
|
DNA, Complementary | 1 | 1998 | 393 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 1998 | 153 | 0.040 |
Why?
|
Cervix Mucus | 1 | 2016 | 4 | 0.040 |
Why?
|
Perimenopause | 1 | 2016 | 3 | 0.040 |
Why?
|
Sex Distribution | 1 | 2016 | 173 | 0.030 |
Why?
|
Circular Dichroism | 3 | 2000 | 117 | 0.030 |
Why?
|
Prognosis | 2 | 2016 | 3669 | 0.030 |
Why?
|
Models, Molecular | 4 | 2000 | 1284 | 0.030 |
Why?
|
Psychometrics | 1 | 2016 | 327 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2019 | 1822 | 0.030 |
Why?
|
Checklist | 1 | 2015 | 57 | 0.030 |
Why?
|
Biomarkers | 2 | 2011 | 1709 | 0.030 |
Why?
|
Public Health | 1 | 2013 | 129 | 0.030 |
Why?
|
Microscopy, Polarization | 2 | 2000 | 10 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 399 | 0.020 |
Why?
|
Calorimetry, Differential Scanning | 2 | 2000 | 12 | 0.020 |
Why?
|
Regression Analysis | 1 | 2011 | 595 | 0.020 |
Why?
|
Thermodynamics | 2 | 2000 | 308 | 0.020 |
Why?
|
Linear Models | 1 | 2010 | 419 | 0.020 |
Why?
|
Survival Analysis | 1 | 2010 | 1536 | 0.020 |
Why?
|
Animals | 3 | 2000 | 26518 | 0.020 |
Why?
|
Inflammation | 1 | 2010 | 913 | 0.020 |
Why?
|
Poly U | 1 | 2000 | 6 | 0.010 |
Why?
|
Spectrophotometry | 1 | 2000 | 106 | 0.010 |
Why?
|
Chloroform | 1 | 2000 | 4 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2000 | 177 | 0.010 |
Why?
|
Adenine | 1 | 2000 | 85 | 0.010 |
Why?
|
Polynucleotides | 1 | 2000 | 17 | 0.010 |
Why?
|
Hydrogen Bonding | 1 | 2000 | 144 | 0.010 |
Why?
|
Cattle | 1 | 2000 | 374 | 0.010 |
Why?
|
Heating | 1 | 1999 | 14 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1999 | 43 | 0.010 |
Why?
|
Nucleic Acid Denaturation | 1 | 1999 | 34 | 0.010 |
Why?
|
Models, Chemical | 1 | 2000 | 178 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2000 | 408 | 0.010 |
Why?
|
Thymus Gland | 1 | 2000 | 195 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2000 | 318 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2000 | 193 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 433 | 0.010 |
Why?
|
Adenosine | 1 | 2000 | 224 | 0.010 |
Why?
|